Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China

Yuankai Shi, Ying Han, Jianliang Yang, Peng Liu, Xiaohui He, Changgong Zhang, Shengyu Zhou, Liqiang Zhou, Yan Qin, Yong-Wen Song, Yueping Liu, Shulian Wang, Jing Jin, Lin Gui, Yan SunChinese 2019 · DOI

Abstract

<sec><b>Objective</b>To explore the clinicobiologic features and outcomes of diffuse large B-cell lymphoma (DLBCL) patients in China according to the primary site.</sec><sec><b>Methods</b>A total of 1,085 patients diagnosed with DLBCL in National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College during a 6-year period were enrolled. Their clinical characteristics and outcomes were analyzed according to the primary site.</sec><sec><b>Results</b>In the 1,085 patients, 679 (62.6%) cases were nodal DLBCL (N-DLBCL) and 406 cases (37.4%) were extranodal DLBCL (EN-DLBCL). The most common sites of N-DLBCL were lymphonodus (64.8%), Waldeyer’s ring (19.7%), mediastinum (12.8%) and spleen (2.7%), while in EN-DLBCL, stomach (22.4%), intestine (16.0%), nose and sinuses (8.9%), testis (8.4%), skin (7.9%), thyroid (6.9%), central nervous system (CNS) (6.4%), breast (5.7%), bone (3.4%), and salivary gland (2.7%) were most common. N-DLBCL patients tend to present B symptoms, bulky disease, and elevated LDH more often, while age &gt;60 years, extranodal sites &gt;1, Ann Arbor stage I or II, bone marrow involvement, and Ki-67 index &gt;90% were usually seen in EN-DLBCL. The 5-year overall survival (OS) rate and progression-free survival (PFS) rate for all patients were 62.5% and 54.2%. The 5-year OS rate for patients with N-DLBCL and EN-DLBCL were 65.5% and 56.9% (P=0.008), and the 5-year PFS were 57.0% and 49.0% (P=0.020). Waldeyer’s ring originated DLBCL possessed the highest 5-year OS rate (83.6%) and PFS rate (76.9%) in N-DLBCL. The top five EN-DLBCL subtypes with favorable prognosis were stomach, breast, nose and sinuses, lung, salivary gland, with 5-year OS rate: 70.3%, 69.6%, 69.4%, 66.7% and 63.6%, respectively. While CNS, testis, oral cavity and kidney originated EN-DLBCL faced miserable prognosis, with 5-year OS rate of 26.9%, 38.2%, and 42.9%.</sec><sec><b>Conclusions</b>In our study, primary sites were associated with clinical characteristics and outcomes. Compared with EN-DLBCL, N-DLBCL had better prognosis.</sec>
BibTeX
@inproceedings{shi2019clinical,
  author = {Yuankai Shi and Ying Han and Jianliang Yang and Peng Liu and Xiaohui He and Changgong Zhang and Shengyu Zhou and Liqiang Zhou and Yan Qin and Yong-Wen Song and Yueping Liu and Shulian Wang and Jing Jin and Lin Gui and Yan Sun},
  title = {{Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China}},
  booktitle = {Chinese},
  year = {2019},
  doi = {10.21147/j.issn.1000-9604.2019.01.10},
}

Loading related content...

Figure